0
     

Report Added
Report already added
In Vitro Toxicology Testing Market by Product (Assays (Western Blot, Tissue Culture), Equipment, Consumables, Software), Toxicity Endpoints (ADME, Skin Irritation, Cytotoxicity), Technology, Method, Industry (Pharma,Biotech) - Global Forecast to 2027

In Vitro Toxicology Testing Market by Product (Assays (Western Blot, Tissue Culture), Equipment, Consumables, Software), Toxicity Endpoints (ADME, Skin Irritation, Cytotoxicity), Technology, Method, Industry (Pharma,Biotech) - Global Forecast to 2027

The in vitro toxicology testing market is expected to reach USD 18.6 billion by 2027 from an estimated USD 11.2 billion in 2022, at a CAGR of 10.8%. Factors such as, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development are the factors to drive the market

“The ADME segment is expected to account for the largest market share in 2021.”

Based on toxicity endpoints and tests undertaken across all industries, the in vitro toxicity testing market is segmented into genotoxicity; cytotoxicity; ADME; skin irritation, corrosion, & sensitization; ocular toxicity; organ toxicity; phototoxicity; dermal toxicity; and other endpoints & tests. In 2021, the ADME segment accounted for the largest share of the in vitro toxicity testing market.

“During the forecast period, the software segment is expected to grow at the highest rate.”

On the basis of product and service, the in vitro toxicology testing market is segmented into consumables, assays, equipment, software, and services. Due to the increasing use of softwares in industry, the software segment is projected to witness the highest growth in the in vitro toxicology testing market during the forecast period.

“During the forecast period, toxicogenomics is expected to grow at the highest rate.”

During the forecast period, the toxicogenomics segment is expected to grow at the highest CAGR, due to the technological advancements taking place in the field of genomics and proteomics.

“In 2021, Europe is expected to hold the largest share for players operating in the in vitro toxicology testing market.”

In 2021, Europe accounted for the largest share of the in vitro toxicology testing market. Factors such as high adoption of in vitro toxicology testing assays and services in the chemical and cosmetics industries in the region are among the primary reasons expected to contribute to the growth of this market.

A breakdown of the primary participants referred to for this report is provided below:
•By Company Type: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
•By Designation: C-level (35%), Director-level (25%), and Others (40%)
•By Region: North America (45%), Europe (30%), Asia Pacific (20%), Latin America (3%), and the Middle East & Africa (2%)

Key players in the In Vito Toxiocology Testing Market
The prominent players in the in vitro toxicology testing market include Thermo Fisher Scientific Inc. (US), Laboratory Corporation of America Holdings (US), Bio-Rad Laboratories, Inc. (US), General Electric Company (US), Eurofins Scientific (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Evotec (UK), SGS S.A. (Switzerland), QIAGEN (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), MB Research Laboratories (US) ,Creative Biolabs(US), GVK Biosciences Private Limited (India), Shanghai Medicon Inc (China), Creative Biorray (US) and Insphero (Switzerland).

Research Coverage:
The report aims at estimating the market size and future growth potential of the global in vitro toxicology testing market and its product & service, technology, toxicity endpoint & test, industry, method, and regional segments. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:
•Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global in vitro toxicology testing market
•Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the global in vitro toxicology testing market
•Market Development: Comprehensive information on the lucrative emerging regions
•Market Diversification: Exhaustive information about the new product, growing geographies, and recent developments in the global in vitro toxicology testing market
•Competitive Assessment: In-depth assessment of market ranking, growth strategies, revenue analysis, and services of leading players in the global in vitro toxicology testing market
Table of Contents

1INTRODUCTION44
1.1STUDY OBJECTIVES44
1.2MARKET DEFINITION44
1.2.1INCLUSIONS AND EXCLUSIONS44
1.2.2MARKETS COVERED45
FIGURE 1IN VITRO TOXICOLOGY TESTING MARKET45
FIGURE 2IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC SCOPE46
1.2.3YEARS CONSIDERED FOR STUDY46
1.3CURRENCY47
1.4STAKEHOLDERS47
1.5LIMITATIONS47
1.6SUMMARY OF CHANGES47
2RESEARCH METHODOLOGY49
2.1RESEARCH APPROACH49
FIGURE 3RESEARCH DESIGN49
2.1.1SECONDARY RESEARCH49
2.1.1.1Key data from secondary sources50
2.1.2PRIMARY RESEARCH51
2.1.2.1Key data from primary sources51
2.1.2.2Breakdown of primaries52
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION52
2.2MARKET SIZE ESTIMATION & VALIDATION APPROACH52
FIGURE 5MARKET SIZE APPROACH54
FIGURE 6BOTTOM-UP APPROACH54
2.3DATA TRIANGULATION APPROACH55
FIGURE 7DATA TRIANGULATION METHODOLOGY55
2.4MARKET SHARE ESTIMATION56
2.5ASSUMPTIONS FOR STUDY56
3EXECUTIVE SUMMARY57
FIGURE 8IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2022 VS. 2027 (USD MILLION)57
FIGURE 9IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2022 VS. 2027 (USD MILLION)58
FIGURE 10IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022 VS. 2027 (USD MILLION)59
FIGURE 11IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022 VS. 2027 (USD MILLION)59
FIGURE 12IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022 VS. 2027 (USD MILLION)60
FIGURE 13GEOGRAPHIC ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET61
4PREMIUM INSIGHTS62
4.1IN VITRO TOXICOLOGY TESTING MARKET OVERVIEW62
FIGURE 14OPPOSITION TO ANIMAL TESTING IS MAJOR FACTOR
DRIVING MARKET GROWTH62
4.2ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD63
FIGURE 15CELLULAR ASSAYS HELD LARGEST SHARE OF IN VITRO TOXICOLOGY TESTING MARKET IN ASIA PACIFIC IN 202163
4.3IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES64
FIGURE 16CHINA IS LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL IN VITRO TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD64
4.4IN VITRO TOXICOLOGY TESTING MARKET, BY REGION65
FIGURE 17EUROPE WILL CONTINUE TO DOMINATE IN VITRO TOXICOLOGY TESTING MARKET IN 202765
4.5IN VITRO TOXICOLOGY TESTING MARKET: DEVELOPED VS. DEVELOPING MARKETS65
FIGURE 18DEVELOPING MARKETS TO REGISTER HIGHER CAGR THAN DEVELOPED MARKETS THROUGHOUT FORECAST PERIOD65
5MARKET OVERVIEW66
5.1INTRODUCTION66
5.2MARKET DYNAMICS66
FIGURE 19IN VITRO TOXICOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES66
5.2.1MARKET DRIVERS67
5.2.1.1Public opposition to animal testing67
5.2.1.2Technological advancements in toxicology67
5.2.1.3R&D on early-stage toxicity detection68
5.2.2MARKET RESTRAINTS68
5.2.2.1Reluctance of some regulatory authorities to adopt alternative toxicology testing methods68
5.2.2.2Failure to establish intricacies of in-vivo conditions69
5.2.2.3Lack of in vitro models to study complex endpoints69
5.2.3MARKET OPPORTUNITIES69
5.2.3.1Growing focus on drug discovery and personalized medicine using in vitro methods69
5.2.3.2Increasing number of toxicology databases70
5.2.4MARKET CHALLENGES71
5.2.4.1Dearth of skilled professionals in toxicity testing71

6INDUSTRY INSIGHTS72
6.1INTRODUCTION72
6.2INDUSTRY TRENDS72
6.2.1INCREASING FOCUS ON PREDICTIVE TOXICOLOGY72
6.3SUPPLY CHAIN ANALYSIS73
FIGURE 20SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET73
6.4REGULATORY COMMITTEE ACTIVITIES73
6.4.1MAJOR STAKEHOLDERS74
6.4.2KEY INFLUENCERS74
6.5COVID-19 IMPACT ON IN VITRO TOXICOLOGY MARKET75
FIGURE 21IMPACT OF COVID-19 ON IN VITRO TOXICOLOGY TESTING MARKET76
6.6PORTER’S FIVE FORCES ANALYSIS76
TABLE 1PORTER’S FIVE FORCES ANALYSIS76
6.6.1THREAT OF NEW ENTRANTS77
6.6.2THREAT OF SUBSTITUTES77
6.6.3BARGAINING POWER OF SUPPLIERS77
6.6.4DEGREE OF COMPETITIVE RIVALRY77
6.7TECHNOLOGY ANALYSIS77
7IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE79
7.1INTRODUCTION80
7.2COVID-19 IMPACT, BY PRODUCT & SERVICE80
FIGURE 22CONSUMABLES TO CAPTURE MAJORITY OF MARKET SHARE IN 202280
TABLE 2IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2019–2021 (USD MILLION)81
TABLE 3IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2022–2027 (USD MILLION)81
7.3CONSUMABLES82
7.3.1CONSUMABLES TO ACCOUNT FOR LARGER MARKET SHARE THAN OTHER PRODUCTS IN 202282
TABLE 4IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)83
TABLE 5IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)84
7.4ASSAYS84
TABLE 6ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY TYPE,
2019–2021 (USD MILLION)85
TABLE 7ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY TYPE,
2022–2027 (USD MILLION)85
TABLE 8ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2019–2021 (USD MILLION)86
TABLE 9ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2022–2027 (USD MILLION)86
7.4.1BACTERIAL TOXICITY ASSAYS87
7.4.1.1Bacterial assays to capture largest market share in coming years owing to their increasing adoption across several industries87
TABLE 10BACTERIAL TOXICITY ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION)87
TABLE 11BACTERIAL TOXICITY ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)88
7.4.2ENZYME TOXICITY ASSAYS88
7.4.2.1Enzyme toxicity assays are increasingly used in endocrine-disrupting studies—major factor driving market growth88
TABLE 12ENZYME TOXICITY ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION)89
TABLE 13ENZYME TOXICITY ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)89
7.4.3CELL-BASED ELISA & WESTERN BLOTS90
7.4.3.1Cell-based assays are cost-effective, thereby witnessing increasing adoption in drug discovery90
TABLE 14CELL-BASED ELISA & WESTERN BLOTS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)91
TABLE 15CELL-BASED ELISA & WESTERN BLOTS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)91
7.4.4RECEPTOR-BINDING ASSAYS92
7.4.4.1Receptor-binding assays are suitable for high-throughput formats, thereby exhibiting accelerated demand92
TABLE 16RECEPTOR-BINDING ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION)92
TABLE 17RECEPTOR-BINDING ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)93
7.4.5TISSUE CULTURE ASSAYS93
7.4.5.1Tissue culture assays can mimic in-vivo tissue architecture, thereby attracting researchers93
TABLE 18TISSUE CULTURE ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION)94
TABLE 19TISSUE CULTURE ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)94
7.4.6OTHER ASSAYS95
TABLE 20OTHER ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)95
TABLE 21OTHER ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)96
7.5EQUIPMENT96
7.5.1FULLY AUTOMATED IN VITRO TOXICOLOGY EQUIPMENT ARE INCREASINGLY ADOPTED IN RESEARCH96
TABLE 22EQUIPMENT: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)97
TABLE 23EQUIPMENT: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)98

7.6SOFTWARE98
7.6.1SOFTWARE SOLUTIONS ARE VITAL IN REDUCING ANALYSIS TIME AND MANAGING LARGE VOLUMES OF DATA GENERATED DURING OPERATIONS98
TABLE 24SOFTWARE: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2019–2021 (USD MILLION)99
TABLE 25SOFTWARE: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2022–2027 (USD MILLION)100
7.7SERVICES100
7.7.1LACK OF INFRASTRUCTURE AND EXPERTISE HAVE DRIVEN RELIANCE ON SERVICE PROVIDERS100
TABLE 26SERVICES: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2019–2021 (USD MILLION)101
TABLE 27SERVICES: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2022–2027 (USD MILLION)102
8IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST103
8.1INTRODUCTION104
FIGURE 23ORGAN TOXICITY TESTING TO REGISTER HIGHEST
CAGR DURING FORECAST PERIOD104
TABLE 28IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2019–2021 (USD MILLION)105
TABLE 29IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2022–2027 (USD MILLION)105
8.2ADME (ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION)106
8.2.1ADME TESTING TO COMMAND IN VITRO TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD106
TABLE 30ADME: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2019–2021 (USD MILLION)107
TABLE 31ADME: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2022–2027 (USD MILLION)107
8.3SKIN IRRITATION, CORROSION, & SENSITIZATION108
8.3.1SKIN IRRITATION, CORROSION, & SENSITIZATION ARE MAJOR ENDPOINTS STUDIED IN COSMETICS INDUSTRY108
TABLE 32SKIN IRRITATION, CORROSION, & SENSITIZATION: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)109
TABLE 33SKIN IRRITATION, CORROSION, & SENSITIZATION: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)109
8.4GENOTOXICITY110
8.4.1REGULATORY AUTHORITIES REVIEW AND VALIDATE HIGHER NUMBER OF GENOTOXICITY TESTS THAN ANY OTHER ENDPOINT, THEREBY PROPELLING MARKET GROWTH110
TABLE 34GENOTOXICITY: IN VITRO TOXICOLOGY TESTING, BY GEOGRAPHY,
2019–2021 (USD MILLION)111
TABLE 35GENOTOXICITY: IN VITRO TOXICOLOGY TESTING, BY GEOGRAPHY,
2022–2027 (USD MILLION)111
8.5CYTOTOXICITY112
8.5.1RISING NEED FOR BIOSAFETY LARGELY CONTRIBUTES TO GROWTH OF CYTOTOXICITY TESTING MARKET112
TABLE 36CYTOTOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)113
TABLE 37CYTOTOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)113
8.6OCULAR TOXICITY TESTING114
8.6.1IN VITRO AND EX-VIVO METHODS ARE GAINING HIGH RECOGNITION FOR OCULAR TOXICITY TESTING114
TABLE 38OCULAR TOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)114
TABLE 39OCULAR TOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)115
8.7ORGAN TOXICITY115
8.7.1HIGH-CONTENT SCREENING AND CELL-BASED ASSAYS ARE USED TO DETECT ORGAN-SPECIFIC TOXICITY115
TABLE 40ORGAN TOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)116
TABLE 41ORGAN TOXICITY: TE IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)117
8.8PHOTOTOXICITY117
8.8.1VALIDATED NON-ANIMAL METHODS ARE USED TO EVALUATE PHOTO SAFETY OF COSMETICS, PHARMACEUTICALS, & CHEMICALS117
TABLE 42PHOTOTOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)118
TABLE 43PHOTOTOXICITY: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)119
8.9DERMAL TOXICITY119
8.9.1IN VITRO METHODS FOR DERMAL TOXICITY TESTING ARE EXPECTED TO GAIN RECOGNITION IN COMING YEARS119
TABLE 44DERMAL TOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)120
TABLE 45DERMAL TOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)121
8.10OTHER ENDPOINTS & TESTS121
TABLE 46OTHER ENDPOINTS & TESTS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION)122
TABLE 47OTHER ENDPOINTS & TESTS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)122
9IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY123
9.1INTRODUCTION124
FIGURE 24TOXICOGENOMICS SEGMENT TO EXHIBIT HIGHEST CAGR IN IN VITRO TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD124
TABLE 48IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION)124
TABLE 49IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION)125

9.2CELL CULTURE125
9.2.1CELL- & TISSUE-BASED TECHNOLOGIES ARE WIDELY ADOPTED
IN IN VITRO TESTING125
TABLE 50CELL CULTURE: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)126
TABLE 51CELL CULTURE: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)126
9.3HIGH-THROUGHPUT127
9.3.1INCREASING USE OF HIGH-CONTENT IMAGING TECHNOLOGIES IN TOXICITY TESTING BOOSTS MARKET GROWTH127
TABLE 52HIGH-THROUGHPUT: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION)128
TABLE 53HIGH-THROUGHPUT: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)128
9.4TOXICOGENOMICS129
9.4.1IMPROVEMENTS IN PROTEOMIC TECHNOLOGIES ENHANCE STUDY OF GENES & PROTEIN ACTIVITIES DURING TOXICITY ANALYSIS129
TABLE 54TOXICOGENOMICS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)129
TABLE 55TOXICOGENOMICS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)130
10IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY131
10.1INTRODUCTION132
FIGURE 25PHARMACEUTICALS & BIOPHARMACEUTICALS INDUSTRY TO HOLD LARGEST MARKET SHARE THROUGHOUT FORECAST PERIOD132
TABLE 56IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION)132
TABLE 57IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)133
10.2COVID-19 IMPACT, BY INDUSTRY133
10.3PHARMACEUTICALS & BIOPHARMACEUTICALS133
10.3.1DRUG ATTRITION RATE LEADS TO HIGH ADOPTION OF IN VITRO TESTING ASSAYS IN EARLY STAGES OF DRUG DEVELOPMENT133
TABLE 58PHARMACEUTICALS & BIOPHARMACEUTICALS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)135
TABLE 59PHARMACEUTICALS & BIOPHARMACEUTICALS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)136
10.4COSMETICS & HOUSEHOLD PRODUCTS136
10.4.1BAN ON ANIMAL TESTING LEADING TO ADOPTION OF IN VITRO ASSAYS FOR SAFETY TESTING136
TABLE 60COSMETICS & HOUSEHOLD PRODUCTS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)137
TABLE 61COSMETICS & HOUSEHOLD PRODUCTS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)138
10.5FOOD138
10.5.1INCREASING FOCUS ON FOOD SAFETY DRIVES REQUIREMENT FOR IN VITRO TOXICOLOGY TESTING PRODUCTS138
TABLE 62TYPES OF TOXICOLOGY TESTS IN FOOD139
TABLE 63FOOD: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2019–2021 (USD MILLION)140
TABLE 64FOOD: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2022–2027 (USD MILLION)141
10.6CHEMICALS141
10.6.1INCREASING FOCUS ON ORGANOID-BASED IN VITRO APPROACHES FOR CHEMICALS TESTING PROPELS MARKET GROWTH141
TABLE 65CHEMICALS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)142
TABLE 66CHEMICALS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)143
11IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD144
11.1INTRODUCTION145
FIGURE 26IN-SILICO MODELS TO RECORD HIGHEST CAGR IN IN VITRO TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD145
TABLE 67IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)145
TABLE 68IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION)146
11.2CELLULAR ASSAYS146
11.2.1DEVELOPMENT OF MULTI-PARAMETER ASSAYS WILL PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES TO MARKET PLAYERS146
TABLE 69CELLULAR ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION)147
TABLE 70CELLULAR ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)148
11.3BIOCHEMICAL ASSAYS148
11.3.1BIOCHEMICAL ASSAYS ARE ADOPTED AT HIGHER RATE IN PHARMACEUTICALS INDUSTRY THAN CHEMICALS AND FOOD INDUSTRIES148
TABLE 71BIOCHEMICAL ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION)149
TABLE 72BIOCHEMICAL ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)150
11.4IN-SILICO MODELS150
11.4.1IN-SILICO MODELS ARE EXPECTED TO WITNESS HIGHEST CAGR
FROM 2022 TO 2027150
TABLE 73IN-SILICO MODELS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION)151
TABLE 74IN-SILICO MODELS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)152
11.5EX-VIVO MODELS152
11.5.1EX-VIVO MODELS ARE WIDELY USED IN SKIN AND EYE TOXICOLOGY TESTING IN COSMETICS INDUSTRY152
TABLE 75EX-VIVO MODELS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)153
TABLE 76EX-VIVO MODELS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)154
12IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHIC ANALYSIS155
12.1INTRODUCTION156
12.2COVID-19 IMPACT, BY REGION156
FIGURE 27IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC SNAPSHOT157
TABLE 77IN VITRO TOXICOLOGY TESTING MARKET, BY REGION,
2019–2021 (USD MILLION)157
TABLE 78IN VITRO TOXICOLOGY TESTING MARKET, BY REGION,
2022–2027 (USD MILLION)158
12.3EUROPE158
FIGURE 28EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT159
TABLE 79EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2019–2021 (USD MILLION)160
TABLE 80EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2022–2027 (USD MILLION)160
TABLE 81EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)161
TABLE 82EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)161
TABLE 83EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION)162
TABLE 84EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION)162
TABLE 85EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)163
TABLE 86EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)163
TABLE 87EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION)164
TABLE 88EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION)164
TABLE 89EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION)164
TABLE 90EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)165
TABLE 91EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)165
TABLE 92EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION)165
12.3.1GERMANY166
12.3.1.1Germany holds the largest share of the European market166
TABLE 93GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)167
TABLE 94GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)167
TABLE 95GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION)168
TABLE 96GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION)168
TABLE 97GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)169
TABLE 98GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)169
TABLE 99GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION)170
TABLE 100GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION)170
TABLE 101GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION)170
TABLE 102GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)171
TABLE 103GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)171
TABLE 104GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION)171
12.3.2UK172
12.3.2.1Rising awareness, growing R&D, and increasing collaborations
for In Vitro Toxicology Testing Market are key indicators of market growth in UK172
TABLE 105UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)173
TABLE 106UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)173
TABLE 107UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION)174
TABLE 108UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022-2027 (USD MILLION)174
TABLE 109UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)175
TABLE 110UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)175
TABLE 111UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION)176
TABLE 112UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION)176
TABLE 113UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION)176
TABLE 114UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)177
TABLE 115UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)177
TABLE 116UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION)177
12.3.3FRANCE178
12.3.3.1Proteomics research initiatives supported by government aid market growth in France178
TABLE 117FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)179
TABLE 118FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)179
TABLE 119FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION)180
TABLE 120FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION)180
TABLE 121FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)181
TABLE 122FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)181
TABLE 123FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION)182
TABLE 124FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION)182
TABLE 125FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION)182
TABLE 126FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)183
TABLE 127FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)183
TABLE 128FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION)183
12.3.4ITALY184
12.3.4.1Italian market growth is mainly driven by increased volume of life sciences research184
TABLE 129ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)184
TABLE 130ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)185
TABLE 131ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION)185
TABLE 132ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION)186
TABLE 133ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)186
TABLE 134ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)187
TABLE 135ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION)187
TABLE 136ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION)188
TABLE 137ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION)188
TABLE 138ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)188
TABLE 139ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)189
TABLE 140ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION)189
12.3.5SPAIN189
12.3.5.1Spain’s growing Chemicals industry stimulates in vitro toxicology testing market growth189
TABLE 141SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)190
TABLE 142SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)190
TABLE 143SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION)191
TABLE 144SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION)191
TABLE 145SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)192
TABLE 146SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)192
TABLE 147SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION)193
TABLE 148SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION)193
TABLE 149SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION)193
TABLE 150SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)194
TABLE 151SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)194
TABLE 152SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION)194
12.3.6REST OF EUROPE195
TABLE 153REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)196
TABLE 154REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)196
TABLE 155REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION)196
TABLE 156REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)197
TABLE 157REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)197
TABLE 158REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)198
TABLE 159REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)198
TABLE 160REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)199
TABLE 161REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)199
TABLE 162REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)199
TABLE 163REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019–2021 (USD MILLION)200
TABLE 164REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022–2027 (USD MILLION)200
12.4NORTH AMERICA201
FIGURE 29NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT202
TABLE 165NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2019–2021 (USD MILLION)202
TABLE 166NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2022–2027 (USD MILLION)203
TABLE 167NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)203
TABLE 168NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)203
TABLE 169NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION)204
TABLE 170NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)204
TABLE 171NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)205
TABLE 172NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)205
TABLE 173NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)206
TABLE 174NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)206
TABLE 175NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)206
TABLE 176NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)207
TABLE 177NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019–2021 (USD MILLION)207
TABLE 178NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022–2027 (USD MILLION)207
12.4.1US208
12.4.1.1US dominates North American market due to growing focus on biomarker discovery and research in structure-based drug design208
TABLE 179US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)209
TABLE 180US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)209
TABLE 181US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION)210
TABLE 182US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION)210
TABLE 183US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)211
TABLE 184US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)211
TABLE 185US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION)212
TABLE 186US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION)212
TABLE 187US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION)212
TABLE 188US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)213
TABLE 189US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)213
TABLE 190US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION)213
12.4.2CANADA214
12.4.2.1Strong support to carry out R&D in pharmaceutical and proteomics fields fosters market growth in Canada214
TABLE 191CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)215
TABLE 192CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)215
TABLE 193CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION)216
TABLE 194CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION)216
TABLE 195CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)217
TABLE 196CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)217
TABLE 197CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION)218
TABLE 198CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION)218
TABLE 199CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION)218
TABLE 200CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)219
TABLE 201CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)219
TABLE 202CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION)219

Report Title: In Vitro Toxicology Testing Market by Product (Assays (Western Blot, Tissue Culture), Equipment, Consumables, Software), Toxicity Endpoints (ADME, Skin Irritation, Cytotoxicity), Technology, Method, Industry (Pharma,Biotech) - Global Forecast to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW